Cannabis Use: Clinical Trials

3 trials for Cannabis Use, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow Cannabis Use: new trials by email Literature Review of Cannabis Use trials Research Report on Cannabis Use

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use
N-Acetyl cysteine, Placebo comparator, Cognitive behavioral therapy (CBT) - Cannabis Use, Tobacco Use Disorder
Phase 4CompletedEllen Herbst412021-08-252026-08-11
Haloperidol for the Treatment of Nausea and Vomiting in the ED
Haloperidol, Ondansetron - Vomiting, Nausea
Phase 4CompletedWestern Michigan University School of Medicine602021-04-012023-06-01
Effects of Pregnancy-associated Hormones on THC Metabolism in Women
Dronabinol - Pregnancy Related, Cannabis Use
Phase 4CompletedUniversity of Washington142020-10-192026-05-06

Narrower conditions

Marijuana Abuse (2)  ·  Abdominal Pain (1)  ·  Nausea (1)  ·  Substance-Related Disorders (1)  ·  Tobacco Use Disorder (1)  ·  Vomiting (1)

Broader conditions

Chemically-Induced Disorders (2)  ·  Mental Disorders (2)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)  ·  Substance-Related Disorders (1)

Interventions

Acetylcysteine (1)  ·  Cognitive Behavioral Therapy (1)  ·  Dronabinol (1)  ·  Haloperidol (1)  ·  Ondansetron (1)

Sponsors

Ellen Herbst (1)  ·  University of Washington (1)  ·  Western Michigan University School of Medicine (1)

Countries

United States (3)

Top investigators

Ellen Herbst, MD (1)  ·  Jessica McCoy, MD (1)  ·  Madeline Martinez Rivas, PhD (1)  ·  Nina Isoherranen, PhD (1)

Results publications

PMID 37271412

NIH funding

P01DA032507 (1)